ArticleJournal of cheminformatics2025
Generating diversity and securing completeness in algorithmic retrosynthesis.
Article in Journal of cheminformatics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Chemical synthesis planning has considerably benefited from advances in the field of machine learning. Neural networks can reliably and accurately predict reactions leading to a given, possibly complex, molecule. In this work we focus on algorithms for assembling such predictions to a full synthesis plan that, starting from simple building blocks, produces a given target molecule, a procedure known as retrosynthesis. Objective functions for this task are hard to define and context-specific. In order to generate a diverse set of synthesis plans for chemists to select from, we capture the concept of diversity in a novel chemical diversity score (CDS). Our experiments show that our algorithm outperforms the algorithm predominantly employed in this domain, Monte-Carlo Tree Search, with respect to diversity in terms of our score as well as time efficiency. SCIENTIFIC CONTRIBUTION: We adapt Depth-First Proof-Number Search (DFPN) (Please refer to https://github.com/Bayer-Group/bayer-retrosynthesis-search for the accompanying source code.) and its variants, which have been applied to retrosynthesis before, to produce a set of solutions, with an explicit focus on diversity. We also make progress on understanding DFPN in terms of completeness, i.e., the ability to find a solution whenever there exists one. DFPN is known to be incomplete, for which we provide a much cleaner example, but we also show that it is complete when reinforced with a threshold-controlling routine from the literature.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.